abstract |
The invention is directed to compounds of Formula I wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically 5 acceptable salts thereot that inhibit protein tyrosine kinases, especially e-fins kinase. |